Fusogenix

By Entos Pharmaceuticals

Fusogenix is a non-toxic formulation platform that delivers nucleic acid therapies, mRNA, miRNA, siRNA and CRISPR effectively to extra-hepatic targets.

Entos Pharmaceuticals is a healthcare biotechnology company that develops precision breakthrough therapies through strategic development partnerships.

John Lewis Ph.D., CEO
john.lewis@entospharma.com